BACKGROUND: The incidence of thick melanoma and related mortality is largely static despite advances in early detection during the last 20 years. Nodular melanoma (NM) accounts for the majority of thick lesions and is difficult to recognize in the early stages of its evolution. OBJECTIVE: The purpose of this study was to identify historic or clinical features that may facilitate earlier detection of NM. METHODS: A questionnaire was administered to 125 patients attending the Victorian Melanoma Service between 1998 and 2000 with superficial spreading melanoma or NM. Parameters were compared by tumor type and thickness. RESULTS: NMs are more often symmetric, elevated, uniform in color, and nonpigmented. Color change is uncommon. CONCLUSION: NM often fails to fulfill the ABCD diagnostic criteria. Biopsy after a set period of observation should aid differentiation from inflammatory lesions and enable earlier detection of this subtype.
BACKGROUND: The incidence of thick melanoma and related mortality is largely static despite advances in early detection during the last 20 years. Nodular melanoma (NM) accounts for the majority of thick lesions and is difficult to recognize in the early stages of its evolution. OBJECTIVE: The purpose of this study was to identify historic or clinical features that may facilitate earlier detection of NM. METHODS: A questionnaire was administered to 125 patients attending the Victorian Melanoma Service between 1998 and 2000 with superficial spreading melanoma or NM. Parameters were compared by tumor type and thickness. RESULTS: NMs are more often symmetric, elevated, uniform in color, and nonpigmented. Color change is uncommon. CONCLUSION: NM often fails to fulfill the ABCD diagnostic criteria. Biopsy after a set period of observation should aid differentiation from inflammatory lesions and enable earlier detection of this subtype.
Authors: Rui Liu; Yu Shi; Hai Jie Yang; Lei Wang; Si Zhang; Yin Yan Xia; Jing Lin Jack Wong; Zhi Wei Feng Journal: J Biol Chem Date: 2011-05-31 Impact factor: 5.157
Authors: Clio Dessinioti; Niki Dimou; Alan C Geller; Aravella Stergiopoulou; Serigne Lo; Ulrike Keim; Jeffrey E Gershenwald; Lauren E Haydu; Simone Ribero; Pietro Quaglino; Susana Puig; Josep Malvehy; Lidija Kandolf-Sekulovic; Tatjana Radevic; Roland Kaufmann; Laura Meister; Eduardo Nagore; Victor Traves; Grigorios G Champsas; Mihaela Plaka; Brigitte Dreno; Emilie Varey; David Moreno Ramirez; Reinhard Dummer; Joanna Mangana; Axel Hauschild; Friederike Egberts; Ketty Peris; Laura Del Regno; Ana-Maria Forsea; Sabina A Zurac; Ricardo Vieira; Ana Brinca; Iris Zalaudek; Teresa Deinlein; Eleni Linos; Evangelos Evangelou; John F Thompson; Richard A Scolyer; Claus Garbe; Alexander J Stratigos Journal: J Natl Cancer Inst Date: 2019-12-01 Impact factor: 13.506
Authors: Melanie A Warycha; Paul J Christos; Madhu Mazumdar; Farbod Darvishian; Richard L Shapiro; Russell S Berman; Anna C Pavlick; Alfred W Kopf; David Polsky; Iman Osman Journal: Cancer Date: 2008-12-15 Impact factor: 6.860
Authors: Bruce Ng; Jan Zakrzewski; Melanie Warycha; Paul J Christos; Dean F Bajorin; Richard L Shapiro; Russell S Berman; Anna C Pavlick; David Polsky; Madhu Mazumdar; Anthony Montgomery; Leonard Liebes; Peter C Brooks; Iman Osman Journal: Clin Cancer Res Date: 2008-10-01 Impact factor: 12.531
Authors: Clio Dessinioti; Alan C Geller; Aravella Stergiopoulou; Susan M Swetter; Eszter Baltas; Jonathan E Mayer; Timothy M Johnson; John Talaganis; Myrto Trakatelli; Dimitrios Tsoutsos; Gerasimos Tsourouflis; Alexander J Stratigos Journal: JAMA Dermatol Date: 2018-05-01 Impact factor: 10.282